Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0001104659-25-079821·Coastlands Capital LP
Schedule 13D ownership disclosure
X4 Pharmaceuticals Inc
Common Stock, par value $0.001 per share · CUSIP: 98420X202
Event date: 2025-08-11
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Coastlands Capital LPReported CIK 0002068530
Shares: 2,479,645.00 · Class: 9.99%
- Coastlands Capital Partners LPReported CIK 0002062655
Shares: 2,479,645.00 · Class: 9.99%
- Coastlands Capital GP LLC
Shares: 2,479,645.00 · Class: 9.99%
- Coastlands Capital LLCReported CIK 0001508612
Shares: 2,479,645.00 · Class: 9.99%
- Matthew D. PerryReported CIK 0001454337
Shares: 2,479,645.00 · Class: 9.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-079821
- Form type
- SCHEDULE 13D
- Filer
- Coastlands Capital LP
- CIK
- CIK 2068530
- Filed
- Aug 18, 2025
- Reporting period
- Aug 11, 2025
- Description
- Schedule 13D beneficial ownership